An increase in the risk of bleeding may nullify the benefits of antiplatelet therapy in patients with chronic kidney disease (CKD), according to a pair of meta-analyses. The evidence from clinical trials included in the meta-analyses is of low quality, the authors reported, with numerous limitations. “Bleeding hazards and lack…
Read more »
indicates a Peer-Reviewed Article
Is chronic kidney disease a coronary heart disease risk equivalent?
Patients with chronic kidney disease (CKD) have an increased risk of myocardial infarction (MI) and a higher MI mortality rate as compared with patients diagnosed with diabetes or who have had a prior MI event, according to a recently published study. “Chronic kidney disease in India is a public health…
Read more »